Healthcare
-
Trump leaves 1.4 million Michiganders hanging on ‘concepts of a plan’ for affordable healthcare
Federal legislation that provides more than 1.4 million Michiganders with affordable access to health insurance could be on the chopping block next year—and ex-President Donald Trump has made clear that he has no real plans to replace it.
-
Everything you need to know about the new flu and COVID vaccines
When it comes to protection against flu and COVID, vaccines are necessary to tackle the latest strains of each. Here’s what you need to know.
-
Detroit health officials warn of West Nile virus risk
After a falcon tested positive for West Nile virus, Detroit officials encouraged residents to take precautions against mosquito bites.
-
Biden-Harris administration’s Medicare drug price negotiations secure $6 billion in savings for taxpayers
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
-
Workforce development program fast-tracks Michigan nurses’ training to ease shortages
The Biden-Harris administration’s American Rescue Plan provided Michigan nursing schools and health care centers with much-needed funding to help them invest in the health care workforce.
-
Harris helped cut insulin prices for 122,000 Michigan seniors
Hundreds of thousands of Michigan seniors, including a Portage manufacturer, are seeing big savings in prescription drug costs, thanks to the Biden-Harris administration.
-
Kamala Harris’ policy priorities are focused on making healthcare more affordable for Michiganders
The American Rescue Plan and Inflation Reduction Act lowered healthcare premiums, lowered drug costs and made vaccines free for Michigan seniors on Medicare, and eliminated medical debt for hundreds of thousands of Michiganders.
-
Major drugmakers capped cost of asthma inhalers at $35 per month after investigation from Democrats
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.
-
Opinion: I was born blind and rely on Medicaid. Cutting it threatens our health and safety
Medicaid offers life-changing support to people with disabilities, lawmakers in Congress must support Medicaid funding in next year’s federal budget.
-
In Detroit, the cost of prescription drugs drives on-the-ground voter outreach
Rates of diabetes and high blood pressure are staggering in Detroit—and cuts to Medicare or Medicaid would make accessing care even more challenging. One political advocate hopes these health care inequities will encourage voter turnout in the city’s urban communities.
